Global Genetic Testing Market Forecast to 2015

NEW YORK, July 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0936052/Global-Genetic-Testing-Market-Forecast-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

"Global Genetic Testing Market Forecast to 2015", provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principal, types and Direct-to-Consumer (DTC) business methodology is also covered in around 95-page report. On account of our analysis of the past and present market trends, drivers, and existing strengths and challenges, forecast for genetic testing has been drawn, according to which, the market is likely to grow at a CAGR of around 26% during 2012-2015.

The report effectively illustrates the role of genetic testing in diseases, such as Cancer, Cystic Fibrosis, and Alzheimer's. It also incorporates the information on disease prevalence, available tests, and genes responsible/discovered that cause a particular disease. An extensive research and reliable statistics in terms of market size, developments and future performance for emerging sectors namely: Next-Generation Sequencing and Genomic Biomarkers are found inside the report.

The report provides comprehensive analytics of key developments for major markets including the US, Canada, the UK, and Germany. These key developments are likely to set the future of genetic testing market in these countries and that is precisely the reason behind their incorporation in the report.

The report also profiles the eight most active genetic testing market players worldwide: Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Myriad Genetics, Life Technologies, Genomic Health, Sequenom and Transgenomic. For the purpose of effective competitive analysis of the market, these companies are analyzed on five major areas namely: business overview, product offering; financial performance for the last three years, strategic analysis of strengths and weaknesses and key developments.1. Analyst View2. Research Methodology3. Introduction to Genetic Testing4. Global Genetic Testing Market Overview4.1 Market Outlook4.2 Genetic Testing Laboratories - Unmet Need Analysis4.3 DTC Genetic Testing5. Disease-Wise Analysis5.1 Alzheimer's Disease5.2 Cystic Fibrosis5.3 Cancer6. Country-Level Analysis6.1 US6.1.1 Companion Diagnostics and LDTs6.1.2 Economical and Social Impact6.1.3 Regulatory Measures6.1.4 Research and Studies6.2 Canada6.2.1 World's First Bedside Genetic Test6.2.2 Physicians' Opinion6.2.3 Information Privacy6.3 UK6.3.1 Role of NICE6.3.2 Newborn Screening: Five Rare Inherited Diseases6.4 Germany6.4.1 Pre-implantation Genetic Diagnosis6.4.2 RAD51C Mutation Screening7. Emerging Sectors7.1 Next-Generation Sequencing7.2 Genomic Biomarkers8. Competitive Assessment8.1 Abbott Laboratories8.1.1 Company Overview8.1.2 Product Offering8.1.3 Financial Overview8.1.4 Key Activities8.1.5 Strengths & Weaknesses8.2 Beckman Coulter8.2.1 Company Overview8.2.2 Product Offering8.2.3 Financial Overview8.2.4 Key Activities8.2.5 Strengths & Weaknesses8.3 Roche Diagnostics8.3.1 Company Overview8.3.2 Product Offering8.3.3 Financial Overview8.3.4 Key Activities8.3.5 Strengths & Weaknesses8.4 Myriad Genetics8.4.1 Company Overview8.4.2 Product Offering8.4.3 Financial Overview8.4.4 Key Activities8.4.5 Strengths & Weaknesses8.5 Life Technologies Corporation8.5.1 Company Overview8.5.2 Product Offering8.5.3 Financial Overview8.5.4 Key Activities8.5.5 Strengths & Weaknesses8.6 Genomic Health8.6.1 Company Overview8.6.2 Product Offering8.6.3 Financial Overview8.6.4 Key Activities8.6.5 Strengths & Weaknesses8.7 Sequenom8.7.1 Company Overview8.7.2 Product Offering8.7.3 Financial Overview8.7.4 Key Activities8.7.5 Strengths & Weaknesses8.8 Transgenomic8.8.1 Company Overview8.8.2 Product Offering8.8.3 Financial Overview8.8.4 Key Activities8.8.5 Strengths & Weaknesses

List of Figures:

Figure 4-1: Molecular Diagnostics Market (Billion US$), 2008-2011Figure 4-2: Genetic Testing Market (Billion US$), 2008-2011Figure 4-3: Forecast for Molecular Diagnostics Market (Billion US$), 2012-2015Figure 4-4: Forecast for Genetic Testing Market (Billion US$), 2012-2015Figure 4-5: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)Figure 4-6: Number of DTC Genetic Testing Companies by CountryFigure 6-1: Number of Laboratories and Diseases for Genetic Testing (1993-2010)Figure 8-1: Global - Next Generation Sequencing Market (Billion US$), 2011-2015Figure 8-2: Global - NGS Application by Sector (%)Figure 8-3: Global - Next Generation Sequencing Market by Player (%), 2010

List of Tables:

Table 4-1: Genetic Testing Labs Penetration in Key CountriesTable 4-2: Key Companies in DTC Genetic Testing SegmentTable 5-1: Test Availability and Market Size for Key ConditionsTable 7-1: Listed Pharmacogenomic Biomarkers in FDA Approved Cancer Therapy LabelsTable 9-1: Abbott Molecular - Key Gene Based Product(s)Table 9-2: Abbott Laboratories - Financial Performance (Million US$), 2009-2011Table 9-3: Beckman Coulter - Key Gene Based Product(s)Table 9-4: Beckman Coulter - Financial Performance (Million US$), 2008-2010Table 9-5: Roche Molecular Diagnostics - Key Gene Based Product(s)Table 9-6: Roche Holding - Financial Performance (Million US$), 2009-2011Table 9-7: Myriad Genetics - Key Gene Based Product(s)Table 9-8: Myriad Genetics - Financial Performance (Million US$), 2009-2011Table 9-9: Life Technologies - Key Gene Based Product(s)Table 9-10: Life Technologies - Financial Performance (Million US$), 2009-2011Table 9-11: Genomic Health - Key Gene Based Product(s)Table 9-12: Genomic Health - Financial Performance (Million US$), 2009-2011Table 9-13: Sequenom - Key Gene Based Product(s)Table 9-14: Sequenom - Financial Performance (Million US$), 2009-2011Table 9-15: Transgenomic - Financial Performance (Million US$), 2009-2011

More  

Check our  

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker